Article Data

  • Views 265
  • Dowloads 135

Original Research

Open Access

Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium

  • T. Pekin1,*,
  • B. YIldIzhan2
  • F. Eren3
  • O. Pekin4
  • R. Yildizhan2

1Dept. of Gynecological Oncology, Mannara University Hospital, Istanbul, Turkey

2Dept. of Gynecology and Obstetrics, Goztepe S.S.K. Hospital, Istanbul, Turkey

3Dept. of Pathology, Mannara University Hospital, Istanbul, Turkey

4Zeynep Kamil Maternity and Children'.I'Hospital, Istanbul, Turkey

DOI: 10.12892/ejgo200102151 Vol.22,Issue 2,March 2001 pp.151-153

Published: 10 March 2001

*Corresponding Author(s): T. Pekin E-mail:

Abstract

Purpose: To determine the frequency of endometrial adenocarcinoma (AC) with squamous cell differentiation and to compare the histopathologic and clinical characteristics of patients with adenoacanthoma (AA) and adenosquamous carcinoma (AS) to evaluate possible prognostic differences.

Materials and methods: Two hundred forty patients with endometrial carcinoma (72.2% AC, 21.25% AA, 6.25% AS) treated at the Department of Gynecologic Oncology of Marmara University Hospital, between January 1986 and December 1997, were reviewed. The diagnoses of the diseases were made with fractional D&C, and the definitive therapy for all patients was carried out at the same hospital. Extrafascial hysterectomy + BSO with or without pelvic and para-aortic lymph node dissection, and omentectomy according to the FIGO staging and grading system were performed.

Results: AC and AS had median ages around 60 years with a similar percent distribution of postmenopausal patients (around 74%). AA had an earlier median age of 51 years which reflects an incidence of only 50% postmenopausal patients. There was a tendency for AA to be of low-grade malignancy (72%), 51% of AC were of low-grade, while only 20% of AS were low-grade tumors. There was no difference for any of the three pathological entities in survival by FIGO stages. Over 80% of the tumors were Stage I and about 10% were Stage II, with less than 10% in Stages III and IV.

Conclusion: Considering the more modern and uniform approaches in therapy for these tumors, there seems to be no differences in prognosis for adenocarcinoma with or without squamous elements. The neoplasms AC, AA and AS should be regarded, and consequently approached, as any low-grade adenocarcinoma of the endometrium.

Keywords

Adenocarcinoma; Adenoacanthoma; Adenosquamous carcinoma

Cite and Share

T. Pekin,B. YIldIzhan,F. Eren,O. Pekin,R. Yildizhan. Adenocarcinoma, adenoacanthoma, and mixed adenosquamous carcinoma of the endometrium. European Journal of Gynaecological Oncology. 2001. 22(2);151-153.

References

[1] Kurman R. J., Zaino R. J., Norris H.J.: "Endometrial carcinoma". In: Kurman R. J., ed. "P athology of the Female Genital Tract", 4th ed. New York, Springer-Verlag, 1994, 461.

[2] Ng A. B. P., Reagan J. W., Storaasli J. P., Wentz W. B.: "Mixed adenosquamous carcinoma of the endometrium". Am. J. Clin. Pathol., 1973, 59, 765.

[3] Albershasky R. C., Connelly P. J., Christopherson W. M.: "Carcinoma of the endometrium. IV. Mixed adenosquamous carcinoma. A clinicopathological study of 68 cases with long-term followup". Am. Clin. Pathol., 1982, 77, 655.

[4] Salazar 0. M., DeP ap E. W., Bonfiglio T. A., Feldstein M. K., Rubin P., Rudolph J. H.: "Adenosquamous carcinoma of the endometrium. An entity with an inherent poor prognosis?". Cancer, 1977, 40, 119.

[5] Abeler V. M., Kjorstad K. E.: "Endometrial adenocarcinoma with squamous cell differentiation". Cancer, 1992, 69, 488.

[6] Zaino R. J., Kurman R. J., Herbold D., Gliedman J., Bundy N., Voet R., Advani H.: "The squamous differentiation in endometrial carcinoma: Data from a Gynecologic Oncology Group Study". Cancer, 1991, 68, 2293.

[7] Ng A. B. P., Reagan J. W.: "Incidence and prognosis of endometrial carcinoma of histologic grade and extent". Obstet. Gynecol., 1970, 35, 437.

[8] Gross A. J., Clark V. A.: "Survival distributions: Reliability applications in the biomedical sciences". New York, Wiley and Sons Inc., 1975, 23.

[9] Skinner I. C., McDonald J. R.: "Mixed adenocarcinoma and squamous cell carcinoma of the uterus". Am. J. Obstet. Gynecol., 1940, 40, 258.

[10] Connelly P. J., Alberhasky R. C., Christopherson W. M.: "Carcinoma of the endometrium. III. Analysis of 865 cases of adenocarcinoma and adenoacanthoma". Obstet. Gynecol., 1982, 59, 569.

[11] Ng A. B. P.: "Mixed carcinoma of the endometrium". Am. J. Obstet. Gynecol., 1968, 102, 506.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top